Cellular and T cell engager Immunotherapy
Efficacy and safety of ide-cel with lenalidomide (R) maintenance versus R maintenance alone in adult patients (pts) with NDMM who have suboptimal response to ASCT: phase 3 KarMMa-9 trial
María-Victoria Mateos, MD, PhD
Professor
University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
Salamanca, Spain